ACTOplus Met XR

metformin/sulfasalazine extended release combination with ACTOplus Met XR formulation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ACTOplus Met XR, covering 2023-03-08 to 2023-03-08. Get the full timeline:

Most recent: Clinical Trial Update: ACTOplus Met XR in Treating Patients With Stage I-IV Oral Cavity or Oropharynx Cancer Undergoing Definitive Treatment [Phase 2]

See pricing